Journal
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Volume 10, Issue 12, Pages -Publisher
WILEY
DOI: 10.1161/JAHA.120.019051
Keywords
epicardial adipose tissue; morbid obesity; subcutaneous adipose tissue; transcatheter aortic valve replacement; visceral adipose tissue
Categories
Funding
- Fundacion Interhospitalaria para la Investigacion Cardiovascular (FIC Foundation) via Abbott
Ask authors/readers for more resources
In a study comparing short- and midterm outcomes of morbidly obese patients undergoing transcatheter aortic valve replacement, it was found that although major vascular complications were more common and device success was lower in the obese group, all-cause and cardiovascular mortality at 2 years were similar to the nonobese group. An obesity phenotype with an abdominal visceral adipose tissue:subcutaneous adipose tissue ratio >= 1 was identified as being associated with increased risk of adverse clinical outcomes.
Background There is a paucity of outcome data on patients who are morbidly obese (MO) undergoing transcatheter aortic valve replacement. We aimed to determine their periprocedural and midterm outcomes and investigate the impact of obesity phenotype. Methods and Results Consecutive patients who are MO (body mass index, >= 40 kg/m(2), or >= 35 kg/m(2) with obesity-related comorbidities; n=910) with severe aortic stenosis who underwent transcatheter aortic valve replacement in 18 tertiary hospitals were compared with a nonobese cohort (body mass index, 18.5-29.9 kg/m(2), n=2264). Propensity-score matching resulted in 770 pairs. Pre-transcatheter aortic valve replacement computed tomography scans were centrally analyzed to assess adipose tissue distribution; epicardial, abdominal visceral and subcutaneous fat. Major vascular complications were more common (6.6% versus 4.3%; P=0.043) and device success was less frequent (84.4% versus 88.1%; P=0.038) in the MO group. Freedom from all-cause and cardiovascular mortality were similar at 2 years (79.4 versus 80.6%, P=0.731; and 88.7 versus 87.4%, P=0.699; MO and nonobese, respectively). Multivariable analysis identified baseline glomerular filtration rate and nontransfemoral access as independent predictors of 2-year mortality in the MO group. An adverse MO phenotype with an abdominal visceral adipose tissue:subcutaneous adipose tissue ratio >= 1 (VAT:SAT) was associated with increased 2-year all-cause (hazard ratio [HR], 3.06; 95% CI, 1.20-7.77; P=0.019) and cardiovascular (hazard ratio, 4.11; 95% CI, 1.06-15.90; P=0.041) mortality, and readmissions (HR, 1.81; 95% CI, 1.07-3.07; P=0.027). After multivariable analysis, a (VAT:SAT) ratio >= 1 remained a strong predictor of 2-year mortality (hazard ratio, 2.78; P=0.035). Conclusions Transcatheter aortic valve replacement in patients who are MO has similar short- and midterm outcomes to nonobese patients, despite higher major vascular complications and lower device success. An abdominal VAT:SAT ratio >= 1 identifies an obesity phenotype at higher risk of adverse clinical outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available